Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2005
10/19/2005CN1684966A Novel adenine compound and use thereof
10/19/2005CN1684964A Use of and some novel imidazopyridines
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1684708A Anti-NGF antibodies for the treatment of various disorders
10/19/2005CN1684707A Mucosal combination vaccines for bacterial meningitis
10/19/2005CN1684674A Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683358A Process for extracting total flavone from stem and leaf of scutellaria
10/19/2005CN1683000A Sinusitis pill
10/19/2005CN1682984A Shenerwuwei dripping pill for benefiting qi and nourishing yin and its preparing method
10/19/2005CN1682979A Yinhuang lozenge dripping pill preparation and its preparing method
10/19/2005CN1682974A Chinese medicine preparation for treating acute laryngopharyngitis and its preparing method
10/19/2005CN1682971A Compound isatis root freeze-dried powder injection and its preparing method
10/19/2005CN1682957A Freeze-dried preparation containing honeysuckle flower and astragalus root and its preparing method
10/19/2005CN1682951A Chinese medicine preparation for treating chronic pharyngitis
10/19/2005CN1682926A Ginseng-ophiopogon root freeze-dried powder injection and its preparing method
10/19/2005CN1682912A Chinese medicine preparation for relieving cough, removing phlegm, relieving asthma and anti-inflammation
10/19/2005CN1682899A Health medicine for preventing cold
10/19/2005CN1682896A Medicine for treating infantile inflammation of upper respiratory tract and its preparing method
10/19/2005CN1682895A Medicine for relieving asthma and cough and its preparing method
10/19/2005CN1682890A Health composition for making cigarette with functions of moistening throat and refreshig mouth and its producing method
10/19/2005CN1682883A Sarcandra solid dispersion and its preparing method
10/19/2005CN1682859A Chinese medicine for treating rhinitis
10/19/2005CN1682842A Chinese medicine composition for diminishing-inflammation and detoxication and its preparing method and use
10/19/2005CN1682840A Qiaoruisu coleus dripping pill and its preparing method
10/19/2005CN1682836A Qingkailing dispersing tablet
10/19/2005CN1682828A Yinhuang lung clearing capsule and its preparing method
10/19/2005CN1682821A Compound radical lobelia dripping pill and its preparing method
10/19/2005CN1682820A Shangshan dripping pill for treating toxic heat and internal storage and its preparing method
10/19/2005CN1682817A Throat dripping pill for clearing away heat and toxic material and its preparing method
10/19/2005CN1682816A Xiaoaiping dripping pill for treating various cancers and its preparing method
10/19/2005CN1682756A Supplementing method for exogenous nitric oxide
10/19/2005CN1682755A Material for treating inflammation and pain
10/19/2005CN1682729A Fibrauretin dripping pill and its preparing method
10/19/2005CN1682724A Oral treating agent for treating chronic obstructive disease of lung (COPD) containing ipratropium bromide and salbutamol
10/19/2005CN1682706A Stable oil-in-water emulsion of propyl gallate for vein and its preparing method
10/19/2005CN1223678C Pseudozoogloea particle adjuvant preparation and application
10/19/2005CN1223605C Polypeptide medicine for inhibiting SARS corona virus, and derivatives and use thereof
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223373C Sore throat relieving preparation
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956139 (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005US6955821 Sustained release formulations of guaifenesin and additional drug ingredients
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/13/2005WO2005095412A1 Antiallergic agent
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095362A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094869A1 Compositions and methods for improved mucus function
10/13/2005WO2005094835A1 M3 muscarinic acetylcholine receptor antagonists
10/13/2005WO2005094834A1 Muscarinic acetylcholine receptor antagonists
10/13/2005WO2005094811A1 Pharmaceutical product containing tranilast
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005US20050228336 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/13/2005US20050228184 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050228001 Methods and compositions for treating platelet-related disorders
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227978 Fibrosis inhibitor
10/13/2005US20050227972 treating disorders of the cardiovascular system; adenosine receptor agonists/antagonists
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050227951 Verification of translation
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227280 Proteases
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005CA2602596A1 Compositions and methods for improved mucus function
10/13/2005CA2561883A1 Treatment of impaired respiratory function with gaboxadol
10/13/2005CA2561400A1 Chemical process and new crystalline form
10/13/2005CA2560878A1 Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583741A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
10/12/2005EP1583559A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
10/12/2005EP1583555A1 Use of somatostatin analogs in sleep apnea
10/12/2005EP1583553A2 Therapeutic use of modulators of notch
10/12/2005EP1448196B1 Benzothiazole derivatives as adenosine receptor ligands
10/12/2005EP1370568B1 Chemical compounds
10/12/2005EP1216047B1 Combination of loteprednol and beta2-adrenoceptor agonists and its use by inhalation for the treatment of bronchial asthma
10/12/2005EP1143949B1 19-nor-vitamin d3 compounds with calcemic activity
10/12/2005EP1105104B1 Extended release buccal bioadhesive tablet
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005CN1681823A Furoisoquinoline derivative and its application
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
1 ... 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 ... 878